101 related articles for article (PubMed ID: 15130374)
1. [Analysis of the risk factors for ovarian metastasis in patients with endometrial carcinoma].
Chai Y; Huang XF; Xie X; Lü WG; Ye DF; Chen HZ
Zhonghua Fu Chan Ke Za Zhi; 2004 Mar; 39(3):162-4. PubMed ID: 15130374
[TBL] [Abstract][Full Text] [Related]
2. Percent surface area involvement is a predictor of lymph node metastasis in endometrial cancer.
Axtell AE; Kelley JL; Fader AN; Gupta D; Schwartz B; Comerci JT; Lin Y; Weiand S; Gallion HH; Kanbour-Shakir A
Gynecol Oncol; 2007 Dec; 107(3):482-6. PubMed ID: 17850853
[TBL] [Abstract][Full Text] [Related]
3. [Multivariate analysis of prognostic factors in endometrial carcinoma].
Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK
Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208
[TBL] [Abstract][Full Text] [Related]
4. [Ovarian metastasis from endometrial carcinoma: a report of 22 cases].
Zhou C; Sun J; Sheng X
Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):65-7. PubMed ID: 10921064
[TBL] [Abstract][Full Text] [Related]
5. [Study of the risk factors for ovarian metastasis in patients with endometrial carcinoma].
Li LY; Zeng SY; Wan L; Ao MH
Zhonghua Fu Chan Ke Za Zhi; 2008 May; 43(5):352-5. PubMed ID: 18953868
[TBL] [Abstract][Full Text] [Related]
6. Positive adnexal or uterine serosal involvement in stage IIIC endometrial cancer is an adverse factor for recurrence.
Hétu V; Petignat P; Wu Y; Drouin P; Sauthier P; Provencher D; Gauthier P
Gynecol Obstet Invest; 2009; 67(3):173-7. PubMed ID: 19088481
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of MR imaging for the prediction of myometrial invasion of endometrial carcinoma.
Chung HH; Kang SB; Cho JY; Kim JW; Park NH; Song YS; Kim SH; Lee HP
Gynecol Oncol; 2007 Mar; 104(3):654-9. PubMed ID: 17095081
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis on coexisting ovarian cancer in 976 patients with clinical stage I endometrial carcinoma.
Pan Z; Wang X; Zhang X; Chen X; Xie X
J Obstet Gynaecol Res; 2011 Apr; 37(4):352-8. PubMed ID: 21314805
[TBL] [Abstract][Full Text] [Related]
9. Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer.
Frumovitz M; Slomovitz BM; Singh DK; Broaddus RR; Abrams J; Sun CC; Bevers M; Bodurka DC
J Am Coll Surg; 2004 Sep; 199(3):388-93. PubMed ID: 15325608
[TBL] [Abstract][Full Text] [Related]
10. The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine cancers: a multicenter, retrospective Korean study.
Lee KB; Ki KD; Lee JM; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Jeong DH; Kim KT
Ann Surg Oncol; 2009 Oct; 16(10):2882-7. PubMed ID: 19484311
[TBL] [Abstract][Full Text] [Related]
11. Predictors of final histology in patients with endometrial cancer.
Frumovitz M; Singh DK; Meyer L; Smith DH; Wertheim I; Resnik E; Bodurka DC
Gynecol Oncol; 2004 Dec; 95(3):463-8. PubMed ID: 15581947
[TBL] [Abstract][Full Text] [Related]
12. Coexisting ovarian malignancy in young women with endometrial cancer.
Walsh C; Holschneider C; Hoang Y; Tieu K; Karlan B; Cass I
Obstet Gynecol; 2005 Oct; 106(4):693-9. PubMed ID: 16199623
[TBL] [Abstract][Full Text] [Related]
13. Endometrial endometrioid adenocarcinoma: a pathologic analysis of 827 consecutive cases.
Nofech-Mozes S; Ghorab Z; Ismiil N; Ackerman I; Thomas G; Barbera L; Covens A; Khalifa MA
Am J Clin Pathol; 2008 Jan; 129(1):110-4. PubMed ID: 18089496
[TBL] [Abstract][Full Text] [Related]
14. Histologic grade and perineural invasion are more important than tumor thickness as predictor of nodal metastasis in penile squamous cell carcinoma invading 5 to 10 mm.
Velazquez EF; Ayala G; Liu H; Chaux A; Zanotti M; Torres J; Cho SI; Barreto JE; Soares F; Cubilla AL
Am J Surg Pathol; 2008 Jul; 32(7):974-9. PubMed ID: 18460979
[TBL] [Abstract][Full Text] [Related]
15. Lower uterine segment involvement as a predictor for lymph node spread in endometrial carcinoma.
Madom LM; Brown AK; Lui F; Moore RG; Granai CO; Disilvestro PA
Gynecol Oncol; 2007 Oct; 107(1):75-8. PubMed ID: 17629550
[TBL] [Abstract][Full Text] [Related]
16. Analysis of pathological risk factors for lymph node metastasis in colorectal cancer.
Fang W; Fan B; Xiong B
Hepatogastroenterology; 2009; 56(91-92):663-6. PubMed ID: 19621676
[TBL] [Abstract][Full Text] [Related]
17. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
[TBL] [Abstract][Full Text] [Related]
18. [Clinical analysis of endometrial carcinoma patients aged 45 years and younger].
Gao JS; Shen K; Lang JH; Huang HF; Pan LY; Wu M; Jin Y; Chen QH
Zhonghua Fu Chan Ke Za Zhi; 2004 Mar; 39(3):159-61. PubMed ID: 15130373
[TBL] [Abstract][Full Text] [Related]
19. [Clinical observation of young, middle-aged and elderly women with endometrial carcinoma].
Dai FR; Peng GQ; Zhang Y; Chen CX
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):690-3. PubMed ID: 16708811
[TBL] [Abstract][Full Text] [Related]
20. Coexisting ovarian malignancy in patients with clinical stage I endometrial carcinoma.
Akbayır O; Kuru O; Goksedef P; Numanoglu C; Corbacıoglu A; Cetin A
Arch Gynecol Obstet; 2012 Nov; 286(5):1241-5. PubMed ID: 22688443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
